SUSMED,Inc. (TYO:4263)

Japan flag Japan · Delayed Price · Currency is JPY
557.00
-3.00 (-0.54%)
May 2, 2025, 3:30 PM JST
1.64%
Market Cap 9.36B
Revenue (ttm) 150.00M
Net Income (ttm) -579.00M
Shares Out 16.81M
EPS (ttm) -34.56
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 23,400
Average Volume 83,770
Open 565.00
Previous Close 560.00
Day's Range 554.00 - 565.00
52-Week Range 375.00 - 706.00
Beta 1.43
RSI 52.98
Earnings Date May 9, 2025

About SUSMED,Inc.

SUSMED,Inc. develops and sells therapeutic applications in Japan. It develops smartphone based digital therapeutics applications for diseases with insomnia, breast cancer, and kidney disease. The company also develops and sells development platform for therapeutic apps and clinical trial systems. In addition, it offers medical data analysis and consulting services. The company was incorporated in 2015 and is headquartered in Tokyo, Japan. [Read more]

Industry Medical - Healthcare Information Services
Sector Healthcare
Founded 2015
Employees 39
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4263
Full Company Profile

Financial Performance

In 2024, SUSMED,Inc.'s revenue was 342.00 million, a decrease of -35.47% compared to the previous year's 530.00 million. Losses were -357.00 million, 614.0% more than in 2023.

Financial Statements

News

There is no news available yet.